Incidence of fatal adverse drug reactions: A population based study

British Journal of Clinical Pharmacology

Volumn 65, Issue 4, 2008, Pages 573-579

  Wester, Karin ^a   Jönsson, Anna K ^a   Spigset, Olav ^b,c   Druid, Henrik ^d   Hägg, Staffan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adverse drug reactions; Epidemiology; Mortality; Population based study

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMILORIDE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CARDIOVASCULAR AGENT; CELECOXIB; CITALOPRAM; CLOPIDOGREL; CLOZAPINE; DALTEPARIN; DIPYRIDAMOLE; ENOXAPARIN; ESTROGEN; GLIBENCLAMIDE; HEPARIN; HYDROCHLOROTHIAZIDE; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; PREDNISONE; PROPRANOLOL; ROFECOXIB; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TENECTEPLASE; UNINDEXED DRUG; WARFARIN;

ABDOMINAL BLEEDING; ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BLADDER BLEEDING; BLEEDING; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CAUSE OF DEATH; CYSTITIS; DEATH CERTIFICATE; DRUG FATALITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY DYSFUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT HEMORRHAGE; SEX DIFFERENCE; SWEDEN;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DEATH CERTIFICATES; DRUG THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SWEDEN;

EID: 40549119541     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03064.x     Document Type: Article

References (23)

1. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002 58 : 285 91.
2. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 329 : 15 9.
3. Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm BE, Wahlin A, Dahlqvist R. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002 11 : 65 72.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 279 : 1200 5.
5. Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a University central hospital. Eur J Clin Pharmacol 2002 58 : 479 82.
6. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000 320 : 1036.
7. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigné R. Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen. Eur J Clin Pharmacol 2000 56 : 427 30.
8. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA 1977 237 : 879 81.
9. Bains N, Hunter D. Adverse reporting on adverse reactions. CMAJ 1999 160 : 350 1.
10. World Health Organisation. Mortality Theme Issue: Glossary. Available at http://www.who.International/bulletin/Volumes/84/3/mortality_glossary/en/ (last accessed: 30 May 2007).
11. World Health Organisation. International Drug Monitoring: the Role of National Centres. WHO Technical Report Series 1972, no. 498.
12. World Health Organisation. Causality Assessment of Suspected Adverse Reactions. Available at http://www.who-umc.org/DynPage.aspx?id=22682 (last accessed: 24 November 2006).
13. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: eds. Davies DM, Ferner RE, de Glanville H. Davies's Textbook of Adverse Drug Reactions. Oxford : Oxford University Press, 1991 18 45.
14. World Health Organisation Collaborating Centre for International Drug Monitoring. Adverse reaction terminology. 31 December 1991.
15. The National Board of Health and Welfare Centre for Epidemiology. Causes of Death 2001. Available at http://www.socialstyrelsen.se (last accessed: 30 May 2007).
16. Chyka PA. How many deaths occur annually from adverse drug reactions in the United States? Am J Med 2000 109 : 122 30.
17. Wester K, Jönsson A, Spigset O, Hägg S. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden. Pharmacoepidemiol Drug Saf 2007 16 : 173 80.
18. Tiaden JD, Wenzel E, Berthold HK, Muller-Oerlinghausen B. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Semin Thromb Hemost 2005 31 : 371 80.
19. Läkemedelsindustriföreningen, LIF (The Swedish Association of the Pharmaceutical Industry). Farmacevtiska specialiteter i Sverige 2006 (FASS 2006) (Pharmaceutical Specialities in Sweden-Swedish Physicians Desk Reference). Stockholm : Elanders Tofters, 2006.
20. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 : 71 86.
21. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999 131 : 492 501.
22. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Phamacovigilance Research Group. Eur J Clin Pharmacol 1997 52 : 423 7.
23. Hasford J, Goettler M, Munter KH, Muller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002 55 : 945 50.